<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=716879285080964&amp;ev=PageView&amp;noscript=1">
QuantifEye MPS II device logo

The industry standard for macular pigment measurement

Redefining the approach to age-related eye health issues and risk managementAccurately measuring over 4 million eyes since 2006, the QuantifEye® MPS II applies advanced technology and an intuitive interface for comfortable and accurate macular pigment optical density (MPOD) measurement.

Take patient care to the next level.

MPOD measurement allows eye care professionals to assess a key age-related eye health risk factor, low macular pigment, as well as other visual performance challenges.


The QuantifEye® gives patients a score between 0 (low) and 1 (high) for their macular pigment density. Unfortunately, 78% of the population has suboptimal MPOD scores, but these scores can be improved through nutritional supplementation.

 MPOD Score Scale



Healthy MPOD is important for three specific reasons:

  1. Low MPOD is a key risk factor for age-related eye health complications.
  2. Healthy MPOD blocks harmful blue light from reaching the visual cells in the back of the eye.
  3. MPOD is associated with visual performance benefits like glare, bright light, and night driving.


QuantifEye Features and Benefits:

  • Industry standard in MPOD measurement
  • Is simple, fast and user-friendly
  • Provides a graph for each patient that confirms accuracy
  • Uses a patient-controlled response button
  • Determines patient flicker sensitivity before test begins
  • Drives supplement compliance
  • Is affordable
  • Scientifically validated 


Primary benefits of MPOD measurement:

  • A proactive way to offer your patients the best medical care and value without discounting services and products.
  • A way to learn important information about a patient’s macular health, serving as a biomarker for age-related eye health and other visual performance challenges.
  • The unique opportunity to show patients that supplementation is working.
  • A sense of empowerment to patients because rather than focusing on treatment, you’re educating patients and helping them to be proactive.
  • A chance to gain trust with your existing patients who now spend more money with you and ultimately send you more referrals.
  • An opportunity to distinguish your practice and add a valuable revenue stream.

Device Comparison:

QuantifEye MPS II vs. Densitometer

Points of Comparison QuantifEye* Densitometer**
Ability to store patient name and score in device for later viewing Yes No
Ability to electronically transfer patient MPOD results into EMR Yes No
Graph to assess MPOD measurement accuracy Yes No
Graph to determine if patient understood how to take the exam Yes No
Flicker sensitivity adjustment Yes - Automatic Yes - Manual
Ability to measure central and peripheral MPOD Yes Yes
Ability to estimate peripheral MPOD (time saver) Yes No
Number of purchase options 3 ?
Device operator Technician Patient
Time required to measure MPOD 2-3 minutes 7-10 minutes
Calibration requirements Not necessary Daily (5 minutes)
*EyePromise **Macular Metrics


John Herman, OD, FAAO“I was a very early adopter of QuantifEye MPOD measurement in my practice.  I quickly realized that MPOD testing is a very valuable, if not critical, clinical tool for not only detecting low levels of macular pigment density, but identifying the population at risk for AMD and giving the clinician the ability to follow the progress of treatment plans”. 

John Herman, OD, FAAO

Pittsfield, MA


Shelley Williams, OD"Our relationship with ZeaVision has been one of our best vendor partnerships.  Their trainers installed the QuantifEye MPOD instrument and EyePromise supplements and provided exceptional training for our staff. Our patients, doctors, and staff are very enthusiastic about the new technology.  The program was easy to implement, provides enhanced patient care, and is making our practice more profitable.  Our monthly MPOD testing and supplement profit has averaged $4,000 since implementation."  

Shelley Williams, OD

Columbia, Missouri


burlingame.png"The QuantifEye instrument and EyePromise supplements have enabled us to make a significant, measurable impact on our dry macular degeneration patients’ quality of vision, and has helped us identify those who may be at risk for macular degeneration.  Measuring macular pigment is one of the most useful and important tests we perform.  Hearing first hand from our patients how treating their low macular pigment has improved their quality of life is very rewarding."

Jay Burlingame, OD

Overland Park, KS

Innovate Your Practice Today.

The QuantifEye® Program is trusted as the industry-standard turnkey program for measuring Macular Pigment Optical Density (MPOD) and nutraceutical vision support.


From doctors to athletes, professionals in every field rely on our products and industry-leading insights.


In addition to national eye health studies, we sponsor research with leading university science programs across the country. With research and testing behind the effectiveness of our products, you can be confident that your patients will see results with EyePromise.


Try QuantifEye in Your Practice for 60 Days

As part of the EyePromise QuantifEye Program, you can try the QuantifEye MPS II in your practice for 60-days, risk-free. Additionally, the QuantifEye can be purchased or leased, and EyePromise offers several options and programs to suit all types of practices. 


Your free trial includes:

  • 60-Day, Risk-Free Evaluation
  • Complimentary full day of on-site training
  • Free ongoing staff training, patient education tools, and marketing materials
  • Free Startup Kit

Purchase and leasing options available.QuantifEye_Family-Shot_4-16-19


To learn more about macular pigment measurement, please complete the following form.

Our regional accounts managers are standing by to assist you.


EyePromise 60 Day Money-back Guarantee

ZeaVision LLC BBB Business Review